Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > New Press Release - Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development

<< Previous

Bullboard Posts

Next >>

Comment by whitenorth72on Mar 13, 2024 12:31pm

128 Views

Post# 35930760

RE:RE:New Press Release - Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development

Just guessing but maybe NDAs were signed. From what I have gathered is Rain cage is trying hard to stay under the radar until they are ready to fully promo.
Im very happy about VM and RCs relationship and I believe we are in the right place at the right time.
Like I said just a wishful guess.

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?